Latest papers

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial.

Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture.

Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial.

In vivo assessment of oral administration of probucol nanoparticles in rats.

Effect of the anti-oxidant probucol on soluble thrombomodulin (sTM) in hypercholesterolemic rabbits.

Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30.

Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds.

[Investigation of antiviral properties of new formulations of Panavir in the treatment of experimental herpes virus infection in mice].

Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis.

Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY.

[Adverse effects of lipid-lowering medications].

Relationship between free-radical lipid oxidation and efficiency of coronary angioplasty in coronary patients.

Probucol modulates iron nitrilotriacetate (Fe-NTA)-dependent renal carcinogenesis and hyperproliferative response: diminution of oxidative stress.

Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathway.

Pharmacologic approaches to restenosis prevention.

Probucol does not inhibit myeloperoxidase-dependent low-density lipoprotein oxidation as a potent protective effect in atherosclerosis.

[Drug-induced hypolipoproteinemia]

[Probucol].

AGI-1067, a novel vascular protectant, anti-inflammatory drug and mild antiplatelet agent for treatment of atherosclerosis.

Probucol therapy overcomes the reproductive defect in CTP: phosphocholine cytidylyltransferase beta2 knockout mice.